Published and reported studies used once-weekly subcutaneous administration under trial oversight, with dose escalation used to support tolerability [2], [5], [9]
GLP-1 has also shown signs of carrying out protective and regulatory effects in numerous other tissues, including heart, tongue, adipose, muscles, bones, kidneys, liver, and lungs
In a nutshell, semglutide is a GLP-1 receptor agonist, originally developed for type 2 diabetes
The maintenance dose is almost always lower than the dose that got you to your goal
I am so grateful I found her, and the kind staff
Within the L cells the proglucagon gene is transcribed into proglucagon, which is cleaved by enzymes to form GLP-1